Groupe Francophone des Myelodysplasies Clinical Trial Pipeline: 10 Active Trials

Active trials by phase

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT03223961	A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS	Myelodysplastic Syndromes	Active, Not Recruiting	2026-09-11
Phase 2
NCT07098936	Momelotinib in VEXAS Syndrome	VEXAS Syndome	Recruiting	2026-08-10
NCT05768711	Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic…	Chronic Myeloid Leukemia	Active, Not Recruiting	2026-09-29
NCT03503409	IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome	Myelodysplastic Syndromes	Active, Not Recruiting	2026-08-10
NCT03744390	IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome	Myelodysplastic Syndromes	Active, Not Recruiting	2026-08-10
Phase 1/2
NCT05181735	Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being…	MDS	Recruiting	2026-09-29
NCT05782127	Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk…	Untreated Myelodysplastic Syndrome	Active, Not Recruiting	2026-08-11
NCT05226455	Venetoclax in Patients With MDS or AML in Relapse After AHSCT	MDS	Active, Not Recruiting	2026-03-12
Phase 1
NCT06670222	Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)	Low-risk Myelodysplastic Syndromes	Recruiting	2026-09-10
Not specified
NCT06956755	Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia	Myelodysplastic Syndromes	Recruiting	2026-09-11